Suppr超能文献

血小板活化过程中,血小板因子 XIII 无需释放活化肽即可激活。

Platelet factor XIII becomes active without the release of activation peptide during platelet activation.

作者信息

Muszbek L, Polgár J, Boda Z

机构信息

Department of Clinical Chemistry, University School of Medicine, Debrecen, Hungary.

出版信息

Thromb Haemost. 1993 Mar 1;69(3):282-5.

PMID:8097064
Abstract

The potentially active A subunit of factor XIII of blood coagulation has also been detected in platelets and monocytes/macrophages through the exact function of this cellular protransglutaminase has not yet been elucidated. In physiological conditions the first step in the activation of plasma factor XIII is the removal of an activation peptide from the N-terminal end of subunit A by thrombin. The A subunit then, in the presence of Ca2+, dissociates from the inhibitory B subunit and assumes an active conformation. Cellular factor XIII, which lacks B subunit, can be proteolytically activated in vitro by thrombin and the intracellular Ca2+ sensitive protease, calpain, in the same way as plasma factor XIII subunit A, and calpain has been suggested as the intracellular protease involved in the activation of cellular factor XIII in platelets. In the present experiments it was shown by SDS PAGE that during long-term stimulation of platelets with thrombin nondisulfide-crosslinked high M(r) protein polymers not penetrating the concentrating gel were formed. The lack of these polymers in thrombin-stimulated factor XIII deficient platelets clearly indicated that their formation in normal platelets was due to factor XIII that became active during platelet activation. However, no release of the activation peptide could be detected by Western blotting during this process. Similarly, no proteolytic cleavage of factor XIII was detectable when platelets were stimulated by Ca2+ ionophore through this stimulus activated calpain as it was clearly demonstrated by the breakdown of major intracellular calpain substrates.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

血液凝固因子 XIII 的潜在活性 A 亚基也已在血小板和单核细胞/巨噬细胞中被检测到,不过这种细胞型转谷氨酰胺酶的确切功能尚未阐明。在生理条件下,血浆因子 XIII 激活的第一步是凝血酶从 A 亚基的 N 末端去除一个激活肽。然后,在 Ca2+ 存在的情况下,A 亚基与抑制性 B 亚基解离并呈现活性构象。缺乏 B 亚基的细胞因子 XIII 可以像血浆因子 XIII 亚基 A 一样,在体外被凝血酶和细胞内 Ca2+ 敏感蛋白酶钙蛋白酶水解激活,并且钙蛋白酶被认为是参与血小板中细胞因子 XIII 激活的细胞内蛋白酶。在本实验中,通过 SDS-PAGE 表明,在用凝血酶长期刺激血小板的过程中,形成了不穿透浓缩胶的非二硫键交联的高 M(r) 蛋白聚合物。在凝血酶刺激的因子 XIII 缺陷血小板中缺乏这些聚合物,清楚地表明它们在正常血小板中的形成是由于在血小板激活过程中变得活跃的因子 XIII。然而,在此过程中通过 Western 印迹法未检测到激活肽的释放。同样,当血小板用 Ca2+ 离子载体刺激时,也未检测到因子 XIII 的蛋白水解切割,因为主要细胞内钙蛋白酶底物的分解清楚地表明这种刺激激活了钙蛋白酶。(摘要截断于 250 字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验